{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T19:50:16Z","timestamp":1791316216970,"version":"4.3.1"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:00:00Z","timestamp":1783641600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:00:00Z","timestamp":1791158400000},"content-version":"vor","delay-in-days":87,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"National Cancer Institute","award":["R01CA251589"],"award-info":[{"award-number":["R01CA251589"]}]},{"name":"National Cancer Institute","award":["R01CA251589"],"award-info":[{"award-number":["R01CA251589"]}]},{"name":"National Cancer Institute","award":["R01CA251589"],"award-info":[{"award-number":["R01CA251589"]}]},{"name":"National Cancer Institute","award":["R01CA251589"],"award-info":[{"award-number":["R01CA251589"]}]},{"name":"National Cancer Institute","award":["R01CA251589"],"award-info":[{"award-number":["R01CA251589"]}]},{"name":"National Cancer Institute","award":["R01CA251589"],"award-info":[{"award-number":["R01CA251589"]}]},{"name":"National Cancer Institute","award":["R01CA251589"],"award-info":[{"award-number":["R01CA251589"]}]},{"name":"National Cancer Institute","award":["R01CA251589"],"award-info":[{"award-number":["R01CA251589"]}]},{"name":"National Cancer Institute","award":["R01CA251589"],"award-info":[{"award-number":["R01CA251589"]}]},{"name":"National Cancer Institute","award":["R01CA251589"],"award-info":[{"award-number":["R01CA251589"]}]},{"name":"National Cancer Institute","award":["R01CA251589"],"award-info":[{"award-number":["R01CA251589"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res"],"DOI":"10.1186\/s13058-026-02337-1","type":"journal-article","created":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T03:13:29Z","timestamp":1783653209000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Visceral adiposity and breast cancer outcomes: transcriptomic analysis of the tumor microenvironment by intrinsic subtype"],"prefix":"10.1186","volume":"28","author":[{"given":"Anlan","family":"Cao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophia","family":"Fuller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge G\u00f3mez Tejeda","family":"Za\u00f1udo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy Y.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Dillon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"McAllister","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth A.","family":"Mittendorf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rinath","family":"Jeselsohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bette J.","family":"Caan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Quesenberry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth M.","family":"Cespedes Feliciano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,10]]},"reference":[{"key":"2337_CR1","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1007\/s10549-025-07678-7","volume":"211","author":"A Bellini","year":"2025","unstructured":"Bellini A, et al. The effect of body mass index on breast cancer stage and breast cancer specific survival. Breast Cancer Res Treat. 2025;211:649\u201356. https:\/\/doi.org\/10.1007\/s10549-025-07678-7.","journal-title":"Breast Cancer Res Treat"},{"key":"2337_CR2","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1001\/jamaoncol.2021.1499","volume":"7","author":"EV Bandera","year":"2021","unstructured":"Bandera EV, et al. Association of Body Mass Index, Central Obesity, and Body Composition With Mortality Among Black Breast Cancer Survivors. JAMA Oncol. 2021;7:1186\u201395. https:\/\/doi.org\/10.1001\/jamaoncol.2021.1499.","journal-title":"JAMA Oncol"},{"key":"2337_CR3","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1007\/s12282-022-01355-z","volume":"29","author":"Y Pang","year":"2022","unstructured":"Pang Y, Wei Y, Kartsonaki C. Associations of adiposity and weight change with recurrence and survival in breast cancer patients: a systematic review and meta-analysis. Breast Cancer. 2022;29:575\u201388. https:\/\/doi.org\/10.1007\/s12282-022-01355-z.","journal-title":"Breast Cancer"},{"key":"2337_CR4","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1093\/jnci\/djab023","volume":"113","author":"AE Lohmann","year":"2021","unstructured":"Lohmann AE, et al. Association of Obesity With Breast Cancer Outcome in Relation to Cancer Subtypes: A Meta-Analysis. JNCI: J Natl Cancer Inst. 2021;113:1465\u201375. https:\/\/doi.org\/10.1093\/jnci\/djab023.","journal-title":"JNCI: J Natl Cancer Inst"},{"key":"2337_CR5","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1007\/s10555-022-10043-5","volume":"41","author":"EN Devericks","year":"2022","unstructured":"Devericks EN, Carson MS, McCullough LE, Coleman MF, Hursting SD. The obesity-breast cancer link: a multidisciplinary perspective. Cancer Metastasis Rev. 2022;41:607\u201325. https:\/\/doi.org\/10.1007\/s10555-022-10043-5.","journal-title":"Cancer Metastasis Rev"},{"key":"2337_CR6","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1093\/jnci\/djaa169","volume":"113","author":"J Wang","year":"2020","unstructured":"Wang J, et al. Early-Life Body Adiposity and the Breast Tumor Transcriptome. JNCI: J Natl Cancer Inst. 2020;113:778\u201384. https:\/\/doi.org\/10.1093\/jnci\/djaa169.","journal-title":"JNCI: J Natl Cancer Inst"},{"key":"2337_CR7","doi-asserted-by":"publisher","first-page":"4418","DOI":"10.1038\/s41467-023-39996-z","volume":"14","author":"HL Nguyen","year":"2023","unstructured":"Nguyen HL, et al. Obesity-associated changes in molecular biology of primary breast cancer. Nat Commun. 2023;14:4418. https:\/\/doi.org\/10.1038\/s41467-023-39996-z.","journal-title":"Nat Commun"},{"key":"2337_CR8","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1186\/s12885-015-1263-4","volume":"15","author":"ML Kwan","year":"2015","unstructured":"Kwan ML, et al. Association of high obesity with PAM50 breast cancer intrinsic subtypes and gene expression. BMC Cancer. 2015;15:278. https:\/\/doi.org\/10.1186\/s12885-015-1263-4.","journal-title":"BMC Cancer"},{"key":"2337_CR9","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s40608-016-0103-7","volume":"3","author":"AL Toro","year":"2016","unstructured":"Toro AL, Costantino NS, Shriver CD, Ellsworth DL, Ellsworth RE. Effect of obesity on molecular characteristics of invasive breast tumors: gene expression analysis in a large cohort of female patients. BMC Obes. 2016;3:22. https:\/\/doi.org\/10.1186\/s40608-016-0103-7.","journal-title":"BMC Obes"},{"key":"2337_CR10","doi-asserted-by":"publisher","unstructured":"Fuentes-Mattei E, et al. Effects of Obesity on Transcriptomic Changes and Cancer Hallmarks in Estrogen Receptor\u2013Positive Breast Cancer. JNCI: J Natl Cancer Inst. 2014;106. https:\/\/doi.org\/10.1093\/jnci\/dju158.","DOI":"10.1093\/jnci\/dju158"},{"key":"2337_CR11","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1158\/1940-6207.Capr-24-0514","volume":"18","author":"LA Smith","year":"2025","unstructured":"Smith LA, et al. Weight Loss Reverses the Effects of Aging and Obesity on Mammary Tumor Immunosuppression and Progression. Cancer Prev Res (Phila). 2025;18:453\u201363. https:\/\/doi.org\/10.1158\/1940-6207.Capr-24-0514.","journal-title":"Cancer Prev Res (Phila)"},{"key":"2337_CR12","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1007\/s10549-011-1595-y","volume":"132","author":"CJ Creighton","year":"2012","unstructured":"Creighton CJ, et al. A gene transcription signature of obesity in breast cancer. Breast Cancer Res Treat. 2012;132:993\u20131000. https:\/\/doi.org\/10.1007\/s10549-011-1595-y.","journal-title":"Breast Cancer Res Treat"},{"key":"2337_CR13","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1200\/jco.2008.18.1370","volume":"27","author":"JS Parker","year":"2009","unstructured":"Parker JS, et al. Supervised risk predictor of breast cancer based on intrinsic subtypes. J Clin Oncol. 2009;27:1160\u20137. https:\/\/doi.org\/10.1200\/jco.2008.18.1370.","journal-title":"J Clin Oncol"},{"key":"2337_CR14","doi-asserted-by":"publisher","unstructured":"Li J, Wu J, Han J. Analysis of Tumor Microenvironment Heterogeneity among Breast Cancer Subtypes to Identify Subtype-Specific Signatures. Genes (Basel). 2022;14. https:\/\/doi.org\/10.3390\/genes14010044.","DOI":"10.3390\/genes14010044"},{"key":"2337_CR15","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1038\/ncb3578","volume":"19","author":"DF Quail","year":"2017","unstructured":"Quail DF, et al. Obesity alters the lung myeloid cell landscape to enhance breast cancer metastasis through IL5 and GM-CSF. Nat Cell Biol. 2017;19:974\u201387. https:\/\/doi.org\/10.1038\/ncb3578.","journal-title":"Nat Cell Biol"},{"key":"2337_CR16","doi-asserted-by":"publisher","unstructured":"McDowell SAC, et al. Obesity alters monocyte developmental trajectories to enhance metastasis. J Exp Med. 2023;220. https:\/\/doi.org\/10.1084\/jem.20220509.","DOI":"10.1084\/jem.20220509"},{"key":"2337_CR17","doi-asserted-by":"publisher","unstructured":"Rubino F et al. Definition and diagnostic criteria of clinical obesity. Lancet Diabetes Endocrinol https:\/\/doi.org\/10.1016\/S2213-8587(24)00316-4.","DOI":"10.1016\/S2213-8587(24)00316-4"},{"key":"2337_CR18","doi-asserted-by":"publisher","unstructured":"D\u2019Esposito V, et al. Mammary Adipose Tissue Control of Breast Cancer Progression: Impact of Obesity and Diabetes. Front Oncol. 2020;10\u20132020. https:\/\/doi.org\/10.3389\/fonc.2020.01554.","DOI":"10.3389\/fonc.2020.01554"},{"key":"2337_CR19","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1093\/annonc\/mdr304","volume":"22","author":"A Goldhirsch","year":"2011","unstructured":"Goldhirsch A, et al. Strategies for subtypes\u2013dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011. Ann Oncol. 2011;22:1736\u201347. https:\/\/doi.org\/10.1093\/annonc\/mdr304.","journal-title":"Ann Oncol"},{"key":"2337_CR20","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1158\/1055-9965.Epi-13-1023","volume":"23","author":"C Sweeney","year":"2014","unstructured":"Sweeney C, et al. Intrinsic subtypes from PAM50 gene expression assay in a population-based breast cancer cohort: differences by age, race, and tumor characteristics. Cancer Epidemiol Biomarkers Prev. 2014;23:714\u201324. https:\/\/doi.org\/10.1158\/1055-9965.Epi-13-1023.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2337_CR21","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/1755-8794-5-44","volume":"5","author":"RR Bastien","year":"2012","unstructured":"Bastien RR, et al. PAM50 breast cancer subtyping by RT-qPCR and concordance with standard clinical molecular markers. BMC Med Genomics. 2012;5:44. https:\/\/doi.org\/10.1186\/1755-8794-5-44.","journal-title":"BMC Med Genomics"},{"key":"2337_CR22","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","volume":"1","author":"A Liberzon","year":"2015","unstructured":"Liberzon A, et al. The Molecular Signatures Database (MSigDB) hallmark gene set collection. Cell Syst. 2015;1:417\u201325. https:\/\/doi.org\/10.1016\/j.cels.2015.12.004.","journal-title":"Cell Syst"},{"key":"2337_CR23","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1038\/s41586-023-06130-4","volume":"618","author":"A Gavish","year":"2023","unstructured":"Gavish A, et al. Hallmarks of transcriptional intratumour heterogeneity across a thousand tumours. Nature. 2023;618:598\u2013606. https:\/\/doi.org\/10.1038\/s41586-023-06130-4.","journal-title":"Nature"},{"key":"2337_CR24","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1093\/bioinformatics\/btr260","volume":"27","author":"A Liberzon","year":"2011","unstructured":"Liberzon A, et al. Molecular signatures database (MSigDB) 3.0. Bioinformatics. 2011;27:1739\u201340. https:\/\/doi.org\/10.1093\/bioinformatics\/btr260.","journal-title":"Bioinformatics"},{"key":"2337_CR25","doi-asserted-by":"publisher","unstructured":"Korotkevich G, et al. Fast gene set enrichment analysis. bioRxiv. 2021;060012. https:\/\/doi.org\/10.1101\/060012.","DOI":"10.1101\/060012"},{"key":"2337_CR26","doi-asserted-by":"publisher","unstructured":"Racle J, de Jonge K, Baumgaertner P, Speiser DE, Gfeller D. Simultaneous enumeration of cancer and immune cell types from bulk tumor gene expression data. Elife. 2017;6. https:\/\/doi.org\/10.7554\/eLife.26476.","DOI":"10.7554\/eLife.26476"},{"key":"2337_CR27","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1186\/s13059-016-1070-5","volume":"17","author":"E Becht","year":"2016","unstructured":"Becht E, et al. Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression. Genome Biol. 2016;17:218. https:\/\/doi.org\/10.1186\/s13059-016-1070-5.","journal-title":"Genome Biol"},{"key":"2337_CR28","doi-asserted-by":"publisher","first-page":"W509","DOI":"10.1093\/nar\/gkaa407","volume":"48","author":"T Li","year":"2020","unstructured":"Li T, et al. TIMER2.0 for analysis of tumor-infiltrating immune cells. Nucleic Acids Res. 2020;48:W509\u201314. https:\/\/doi.org\/10.1093\/nar\/gkaa407.","journal-title":"Nucleic Acids Res"},{"key":"2337_CR29","doi-asserted-by":"publisher","first-page":"2930","DOI":"10.1172\/jci91190","volume":"127","author":"M Ayers","year":"2017","unstructured":"Ayers M, et al. IFN-\u03b3-related mRNA profile predicts clinical response to PD-1 blockade. J Clin Invest. 2017;127:2930\u201340. https:\/\/doi.org\/10.1172\/jci91190.","journal-title":"J Clin Invest"},{"key":"2337_CR30","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1007\/s10552-022-01613-7","volume":"33","author":"E Cheng","year":"2022","unstructured":"Cheng E, Kirley J, Cespedes Feliciano EM, Caan BJ. Adiposity and cancer survival: a systematic review and meta-analysis. Cancer Causes Control. 2022;33:1219\u201346. https:\/\/doi.org\/10.1007\/s10552-022-01613-7.","journal-title":"Cancer Causes Control"},{"key":"2337_CR31","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/j.clnu.2024.03.010","volume":"43","author":"TS Poltronieri","year":"2024","unstructured":"Poltronieri TS, P\u00e9rsico RS, Viana LV. Body adipose tissue depots and treatment outcomes for women with breast cancer: A systematic review. Clin Nutr. 2024;43:1033\u201342. https:\/\/doi.org\/10.1016\/j.clnu.2024.03.010.","journal-title":"Clin Nutr"},{"key":"2337_CR32","doi-asserted-by":"publisher","first-page":"3385","DOI":"10.1038\/s41598-022-07143-1","volume":"12","author":"M Palleschi","year":"2022","unstructured":"Palleschi M, et al. Computed tomography based analyses of body mass composition in HER2 positive metastatic breast cancer patients undergoing first line treatment with pertuzumab and trastuzumab. Sci Rep. 2022;12:3385. https:\/\/doi.org\/10.1038\/s41598-022-07143-1.","journal-title":"Sci Rep"},{"key":"2337_CR33","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/s41523-021-00325-6","volume":"7","author":"S Harborg","year":"2021","unstructured":"Harborg S, et al. Overweight and prognosis in triple-negative breast cancer patients: a systematic review and meta-analysis. npj Breast Cancer. 2021;7:119. https:\/\/doi.org\/10.1038\/s41523-021-00325-6.","journal-title":"npj Breast Cancer"},{"key":"2337_CR34","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s10549-024-07538-w","volume":"209","author":"L Vaz-Goncalves","year":"2025","unstructured":"Vaz-Goncalves L, Protani MM, Saunus JM, Colditz GA, Reeves MM. Continental differences in the association between excess body weight and prognosis in triple-negative breast cancer: a meta-analysis. Breast Cancer Res Treat. 2025;209:215\u201327. https:\/\/doi.org\/10.1007\/s10549-024-07538-w.","journal-title":"Breast Cancer Res Treat"},{"key":"2337_CR35","doi-asserted-by":"publisher","first-page":"4429","DOI":"10.1158\/1078-0432.Ccr-06-3045","volume":"13","author":"R Dent","year":"2007","unstructured":"Dent R, et al. Triple-negative breast cancer: clinical features and patterns of recurrence. Clin Cancer Res. 2007;13:4429\u201334. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-06-3045.","journal-title":"Clin Cancer Res"},{"key":"2337_CR36","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/oby.2010.248","volume":"19","author":"SM Camhi","year":"2011","unstructured":"Camhi SM, et al. The relationship of waist circumference and BMI to visceral, subcutaneous, and total body fat: sex and race differences. Obes (Silver Spring). 2011;19:402\u20138. https:\/\/doi.org\/10.1038\/oby.2010.248.","journal-title":"Obes (Silver Spring)"},{"key":"2337_CR37","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1016\/j.jcmg.2014.07.017","volume":"7","author":"RV Shah","year":"2014","unstructured":"Shah RV, et al. Visceral adiposity and the risk of metabolic syndrome across body mass index: the MESA Study. JACC Cardiovasc Imaging. 2014;7:1221\u201335. https:\/\/doi.org\/10.1016\/j.jcmg.2014.07.017.","journal-title":"JACC Cardiovasc Imaging"},{"key":"2337_CR38","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1158\/1055-9965.Epi-24-1167","volume":"34","author":"NC Loro\u00f1a","year":"2025","unstructured":"Loro\u00f1a NC, et al. Metabolic Syndrome and Risks of Breast Cancer Outcomes for Luminal, Triple-Negative, and HER2-Overexpressing Subtypes. Cancer Epidemiol Biomarkers Prev. 2025;34:117\u201324. https:\/\/doi.org\/10.1158\/1055-9965.Epi-24-1167.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2337_CR39","doi-asserted-by":"publisher","unstructured":"Strong AL et al. Obesity Enhances the Conversion of Adipose-Derived Stromal\/Stem Cells into Carcinoma-Associated Fibroblast Leading to Cancer Cell Proliferation and Progression to an Invasive Phenotype. Stem Cells Int 2017, 9216502 (2017). https:\/\/doi.org\/10.1155\/2017\/9216502.","DOI":"10.1155\/2017\/9216502"},{"key":"2337_CR40","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1002\/stem.1857","volume":"33","author":"AL Strong","year":"2015","unstructured":"Strong AL, Burow ME, Gimble JM, Bunnell BA. Concise review: The obesity cancer paradigm: exploration of the interactions and crosstalk with adipose stem cells. Stem Cells. 2015;33:318\u201326. https:\/\/doi.org\/10.1002\/stem.1857.","journal-title":"Stem Cells"},{"key":"2337_CR41","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1158\/0008-5472.Can-14-2744","volume":"75","author":"KE Freese","year":"2015","unstructured":"Freese KE, et al. Adipose-derived stems cells and their role in human cancer development, growth, progression, and metastasis: a systematic review. Cancer Res. 2015;75:1161\u20138. https:\/\/doi.org\/10.1158\/0008-5472.Can-14-2744.","journal-title":"Cancer Res"},{"key":"2337_CR42","doi-asserted-by":"publisher","first-page":"301ra130","DOI":"10.1126\/scitranslmed.3010467","volume":"7","author":"BR Seo","year":"2015","unstructured":"Seo BR, et al. Obesity-dependent changes in interstitial ECM mechanics promote breast tumorigenesis. Sci Transl Med. 2015;7:301ra130. https:\/\/doi.org\/10.1126\/scitranslmed.3010467.","journal-title":"Sci Transl Med"},{"key":"2337_CR43","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1186\/s12967-024-05413-2","volume":"22","author":"M Talia","year":"2024","unstructured":"Talia M, et al. Cancer-associated fibroblasts (CAFs) gene signatures predict outcomes in breast and prostate tumor patients. J Translational Med. 2024;22:597. https:\/\/doi.org\/10.1186\/s12967-024-05413-2.","journal-title":"J Translational Med"},{"key":"2337_CR44","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1038\/s41419-023-06110-6","volume":"14","author":"Y Zhao","year":"2023","unstructured":"Zhao Y, et al. Stromal cells in the tumor microenvironment: accomplices of tumor progression? Cell Death Dis. 2023;14:587. https:\/\/doi.org\/10.1038\/s41419-023-06110-6.","journal-title":"Cell Death Dis"},{"key":"2337_CR45","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1038\/s41571-021-00546-5","volume":"18","author":"Y Chen","year":"2021","unstructured":"Chen Y, McAndrews KM, Kalluri R. Clinical and therapeutic relevance of cancer-associated fibroblasts. Nat Rev Clin Oncol. 2021;18:792\u2013804. https:\/\/doi.org\/10.1038\/s41571-021-00546-5.","journal-title":"Nat Rev Clin Oncol"},{"key":"2337_CR46","doi-asserted-by":"publisher","first-page":"108ra113","DOI":"10.1126\/scitranslmed.3002564","volume":"3","author":"AH Beck","year":"2011","unstructured":"Beck AH, et al. Systematic analysis of breast cancer morphology uncovers stromal features associated with survival. Sci Transl Med. 2011;3:108ra113. https:\/\/doi.org\/10.1126\/scitranslmed.3002564.","journal-title":"Sci Transl Med"},{"key":"2337_CR47","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1007\/s10549-010-0855-6","volume":"125","author":"EM de Kruijf","year":"2011","unstructured":"de Kruijf EM, et al. Tumor-stroma ratio in the primary tumor is a prognostic factor in early breast cancer patients, especially in triple-negative carcinoma patients. Breast Cancer Res Treat. 2011;125:687\u201396. https:\/\/doi.org\/10.1007\/s10549-010-0855-6.","journal-title":"Breast Cancer Res Treat"},{"key":"2337_CR48","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1007\/s10549-013-2571-5","volume":"139","author":"TJ Dekker","year":"2013","unstructured":"Dekker TJ, et al. Prognostic significance of the tumor-stroma ratio: validation study in node-negative premenopausal breast cancer patients from the EORTC perioperative chemotherapy (POP) trial (10854). Breast Cancer Res Treat. 2013;139:371\u20139. https:\/\/doi.org\/10.1007\/s10549-013-2571-5.","journal-title":"Breast Cancer Res Treat"},{"key":"2337_CR49","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.ejso.2012.01.002","volume":"38","author":"AM Moorman","year":"2012","unstructured":"Moorman AM, Vink R, Heijmans HJ, van der Palen J, Kouwenhoven EA. The prognostic value of tumour-stroma ratio in triple-negative breast cancer. Eur J Surg Oncol. 2012;38:307\u201313. https:\/\/doi.org\/10.1016\/j.ejso.2012.01.002.","journal-title":"Eur J Surg Oncol"},{"key":"2337_CR50","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/s41698-021-00163-6","volume":"5","author":"G Griguolo","year":"2021","unstructured":"Griguolo G, et al. Immune microenvironment characterisation and dynamics during anti-HER2-based neoadjuvant treatment in HER2-positive breast cancer. NPJ Precis Oncol. 2021;5:23. https:\/\/doi.org\/10.1038\/s41698-021-00163-6.","journal-title":"NPJ Precis Oncol"},{"key":"2337_CR51","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.ccell.2018.01.011","volume":"33","author":"A Costa","year":"2018","unstructured":"Costa A, et al. Fibroblast Heterogeneity and Immunosuppressive Environment in Human Breast Cancer. Cancer Cell. 2018;33:463\u2013e479410. https:\/\/doi.org\/10.1016\/j.ccell.2018.01.011.","journal-title":"Cancer Cell"},{"key":"2337_CR52","doi-asserted-by":"publisher","first-page":"6352","DOI":"10.3390\/cancers13246352","volume":"13","author":"M Perrone","year":"2021","unstructured":"Perrone M, Talarico G, Chiodoni C, Sangaletti S. Impact of Immune Cell Heterogeneity on HER2\u2009+\u2009Breast Cancer Prognosis and Response to Therapy. Cancers. 2021;13:6352.","journal-title":"Cancers"}],"container-title":["Breast Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13058-026-02337-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-026-02337-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-026-02337-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T19:01:38Z","timestamp":1791313298000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13058-026-02337-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,10]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2337"],"URL":"https:\/\/doi.org\/10.1186\/s13058-026-02337-1","relation":{},"ISSN":["1465-542X"],"issn-type":[{"value":"1465-542X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,10]]},"assertion":[{"value":"2 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This data-only study is approved by the KPNC Institutional Review Board with waiver of informed consent due to the retrospective nature. The research was conducted in accordance with the ethical principles of the Declaration of Helsinki.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"J.G.T.Z. reports ownership of stocks in the biotechnology exchange-traded funds IDNA, IBB, and XBI; owns stocks in Novo Nordisk and GRAIL; and previously owned stocks in the exchange-traded fund CNCR, Adaptive Biotechnologies, 2seventy bio, and bluebird bio. R.J. received research funding from Lilly, Novartis and Recursion and served on advisory boards for Lilly, Pfizer, Astra Zeneca, Novartis and Carrick Therapeutics. D.D. received research funding from Canon, Inc and serves as a consultant for Asuragen (BioTechne), Inc.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"169"}}